Abstract: The present invention relates to the use of a composition for preparing a medicament for the treatment of amyotrophic lateral sclerosis and associated disorders. The composition comprises 3-methyl-1-phenyl-2-pyrazoline-5-one or pharmaceutically acceptable salts thereof and borneol. The medicament is a drug used for delaying the occurrence time of amyotrophic lateral sclerosis and extending the survival time, and for improving memory function defect of amyotrophic lateral sclerosis.
Type:
Grant
Filed:
June 8, 2016
Date of Patent:
February 19, 2019
Assignee:
JIANGSU SIMCERE PHARMACEUTICAL CO., LTD
Inventors:
Shibao Yang, Yao Hua, Zhengping Zhang, Rong Chen, Zhaolong Gong